ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells

European Journal of Immunology

Volumn 30, Issue 4, 2000, Pages 1102-1112

  Boehlk, Sabine ^a   Fessele, Sabine ^a   Mojaat, Anke ^a   Miyamoto, Neil G ^b   Werner, Thomas ^c,d   Nelson, Edward L ^e   Schlöndorff, Detlef ^a   Nelson, Peter J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b BAYER AG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d Genomatix GmbH   (Germany)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CRE element; Lipopolysaccharide; Monocyte; RANTES; Transcriptional regulation

Indexed keywords

CHEMOKINE; DEOXYRIBONUCLEASE I; LIPOPOLYSACCHARIDE; PROTEIN C JUN; RANTES; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FOOTPRINTING; DNA TRANSFECTION; GEL MOBILITY SHIFT ASSAY; GENE INDUCTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

ACTIVATING TRANSCRIPTION FACTOR 3; BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEOXYRIBONUCLEASE I; DNA; DNA FOOTPRINTING; GENES, REPORTER; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENE PROTEINS C-JUN; RANTES; RESPONSE ELEMENTS; RNA, MESSENGER; SEQUENCE DELETION; SUBSTRATE SPECIFICITY; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033995549     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200004)30:4<1102::AID-IMMU1102>3.0.CO;2-X     Document Type: Article

References (43)

1. Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M. and Krensky, A. M., A human T cell-specific molecule is a member of a new gene family. J. Immunol. 1988. 141: 1018-1025.
2. Nelson, P. J., Pattison, J. M. and Krensky, A. M., The Chemokine RANTES. In Thorpe, R. and Mire-Sluis, A. (Eds.) Cytokines. Academic Press, San Diego 1998, pp 433-448.
3. Kuna, P., Reddigari, S. R., Schall, T. J., Rucinski, D., Viksman, M. Y. and Kaplan, A. P., RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J. Immunol. 1992. 149: 636-642.
4. Bischoff, S. C., Krieger, M., Brunner, T., Rot, A., von Tscharner, V., Baggiolini, M. and Dahinden, C. A., RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur. J. Immunol. 1993. 23: 761-767.
5. Alam, R., Stafford, S., Forsythe, P., Harrison, R., Faubion, D., Lett-Brown, M. A. and Grant, J. A., RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 1993. 150: 3442-3448.
6. Kameyoshi, Y., Schroder, J. M., Christophers, E. and Yamamoto, S., Identification of the cytokine RANTES released from platelets as an eosinophil chemotactic factor. Int. Arch. Allergy Immunol. 1994. 104: 49-51.
7. von Luettichau, I., Nelson, P. J., Pattison, J. M., van de Rijn, M., Huie, P., Warnke, R., Wiedermann, C. J., Stahl, R. A., Sibley, R. K. and Krensky, A. M., RANTES chemokine expression in diseased and normal human tissues. Cytokine 1996. 8: 89-98.
8. Grone, H. J., Weber, C., Weber, K. S., Grone, E. F., Rabelink, T., Klier, C. M., Wells, T. N., Proudfood, A. E., Schlondorff, D. and Nelson, P. J., Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J. 1999. 13: 1371-1383.
9. Devergne, O., Marfaing-Koka, A., Schall, T. J. et al., Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells [published erratum appears in J. Exp. Med. 1994. 180: 775]. J. Exp. Med. 1994. 179: 1689-1694.
10. Devergne, O., Marfaing-Koka, A., Schall, T. J. et al., Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells [published erratum appears in J. Exp. Med. 1994. 180: 775]. J. Exp. Med. 1994. 179: 1689-1694.
11. Ziegler-Heitbrock, H. W., The biology of the monocyte system. Eur. J. Cell Biol. 1989. 49: 1-12.
12. Rietschel, E. T., Kirikae, T., Schade, F. U. et al., Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994. 8: 217-225.
13. Ulevitch, R. J. and Tobias, P. S., Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 1999. 11: 19-22.
14. Solomon, K. R., Kurt-Jones, E. A., Saladino, R. A., Stack, A. M., Dunn, I. F., Ferretti, M., Golenbock, D., Fleisher, G. R. and Finberg, R. W., Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. J. Clin. Invest. 1998. 102: 2019-2027.
15. Weinstein, S. L., Gold, M. R. and DeFranco, A. L., Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc. Natl. Acad. Sci. USA 1991. 88: 4148-4152.
16. Kopp, E. B. and Medzhitov, R., The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 1999. 11: 13-18.
17. Shin, H. S., Drysdale, B. E., Shin, M. L., Noble, P., Fisher, S. N. and Paznekas, W. A., Definition of a lipopolysaccharide-responsive element in the 5'-flanking regions of MuRAntes and crg-2. Mol. Cell. Biol. 1994. 14: 2914-2925.
18. VanOtteren, G. M., Strieter, R. M., Kunkel, S. L., Paine, R., 3rd, Greenberger, M. J., Danforth, J. M., Burdick, M. D. and Standiford, T. J., Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol. 1995. 154: 1900-1908.
19. + T cells. Science 1995. 270: 1811-1815.
20. Verani, A., Scarlatti, G., Comar, M., Tresoldi, E., Polo, S., Giacca, M., Lusso, P., Siccardi, A. G. and Vercelli, D., C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 1997. 185: 805-816.
21. Nelson, P. J., Kim, H. T., Manning, W. C., Goralski, T. J. and Krensky, A. M., Genomic organization and transcriptional regulation of the RANTES chemokine gene. J. Immunol. 1993. 151: 2601-2612.
22. Ortiz, B. D., Krensky, A. M. and Nelson, P. J., Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol. Cell. Biol. 1996. 16: 202-210.
23. Lin, R., Heylbroeck, C., Genin, P., Pitha, P. M. and Hiscott, J., Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 1999. 19: 959-966.
24. Ortiz, B. D., Nelson, P. J. and Krensky, A. M., Switching gears during T-cell maturation: RANTES and late transcription, Immunol. Today 1997. 18: 468-471.
25. Song, A., Chen, Y. F., Thamatrakoln, K., Storm, T. A, and Krensky, A. M., RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes, Immunity-1939. 10: 93-103.
26. Moriuchi, H., Moriuchi, M. and Fauci, A. S., Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 1997. 158: 3483-3491.
27. Rao, A., NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 1994. 15: 274-281.
28. McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J. and Maki, R. A., Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996. 15: 5647-5658.
29. Moreau-Gachelin, F., Spi-1/PU.1: an oncogene of the Ets family. Biochim. Biophys. Acta 1994. 1198: 149-163.
30. Lodie, T. A., Savedra, R., Jr., Golenbock, D. T., Van Beveren, C. P., Maki, R. A. and Fenton, M. J., Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 1997. 158: 1848-1856.
31. Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A. and Atchison, M. L., PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity. Mol. Cell. Biol. 1992. 12: 368-378.
32. Wasylyk, B., Wasylyk, C., Flores, P., Begue, A., Leprince, D. and Stehelin, D., The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 1990. 346: 191-193.
33. Hai, T. and Curran, T., Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 1991. 88: 3720-3724.
34. Yamaguchi, Y., Wada, T., Suzuki, F., Takagi, T., Hasegawa, J. and Handa, H., Casein kinase II interacts with the bZIP domains of several transcription factors. Nucleic Acids Res. 1998. 26: 3854-3861.
35. Hambleton, J., Weinstein, S. L., Lem, L. and DeFranco, A. L., Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 1996. 93: 2774-2778.
36. Hiura, T. S., Kempiak, S. J. and Nel, A. E., Activation of the human RANTES gene promoter in a macrophage cell line by lipopolysaccharide is dependent on stress-activated protein kinases and the IkappaB kinase cascade: implications for exacerbation of allergic inflammation by environmental pollutants. Clin, Immunol. 1999. 90: 287-301.
37. Sano, Y., Tokitou, F., Dai, P., Maekawa, T., Yamamoto, T. and Ishii, S., CBP alleviates the intramolecular inhibition of ATF-2 function. J. Biol. Chem. 1998. 273: 29098-29105.
38. Klingenhoff, A., Frech, K., Quandt, K. and Werner, T., Functional promoter modules can be detected by formal models independent of overall nucleotide sequence similarity. Bioinformatics 1999. 15: 180-186.
39. Nelson, E. L., Strobl, S., Subleski, J., Prieto, D., Kopp, W. C. and Nelson, P. J., Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation. FASEB J. 1999. 13: 2021-2030.
40. Ziegler-Heitbrock, H. W. L., Thiel, E., Fütterer, A., Herzog, V., Wirtz, A. and Riethmüller, G., Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 1987. 41: 456-461.
41. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987. 162: 156-159.
42. Leung, S., McCracken, S., Ghysdael, J. and Miyamoto, N. G., Requirement of an ETS-binding element for transcription of the human Ick type I promoter. Oncogene 1993. 8: 989-997.
43. Nelson, P. J., Ortiz, B. D., Pattison, J. M. and Krensky, A. M., Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J. Immunol. 1996. 157: 1139-1148.